Introduction
The first key step of analysing a microbial community is accurately defining the bacterial taxa present. From this, a range of ecological insights can follow in terms of understanding and predicting the impact and response of communities to perturbation. Such approaches have been of importance for some time when assessing the responses of communities present in natural environments (Ager et al., 2010) . More recently, awareness has grown of the benefit of applying these techniques to both normal and pathogenic bacterial communities associated with the human host. In humans, mixed species infections are commonplace (Brogden et al., 2005) ; and, defining the roles exerted by bacteria in chronic lower respiratory infections is particularly important. Taking cystic fibrosis (CF) as a paradigm, the lung damage that results from such infections drives respiratory failure and death in the overwhelming majority of cases (Davis et al., 1996) . Understanding the ecological patterns and processes may allow improvement in therapy. However, before being able to do so, it is important to determine accurately the community characteristics of CF airways.
The 16S rRNA gene pyrosequencing and quantitative PCR (Q-PCR) analysis offer greatly improved accuracy and depth of characterisation of microbial communities. However, although avoiding the selective biases associated with culture-based microbiology, culture-independent approaches will distort to some degree the characteristics of the systems they are being used to describe. For example, standard PCR-based analyses are unable to distinguish between DNA derived from viable and non-viable bacterial cells. In the context of CF lung infections, the combination of poor clearance of airway secretions (Dö ring and Gulbins, 2009 ) and exposure of bacterial cells to a range of antimicrobial challenges, both in the form of host immune response (Elizur et al., 2008) and antibiotic therapy (Ratjen, 2001) , results in substantial non-viable populations (Rogers et al., 2005 (Rogers et al., , 2008 (Rogers et al., , 2010 . As such, the potential contribution of DNA, either from the extracellular environment or from non-viable cells, to microbial community characterisation is considerable.
Failing to limit analysis to DNA from viable bacteria could have a number of effects on community characterisation. These include overestimating viable bacterial density, distorting relative viable species abundance and the masking of less abundant species by dominant species. Further, the impact on community dynamics from antibiotic treatment in this context is less likely to be observed when DNA from bacteria rendered non-viable is not prevented from contributing to molecular analysis. Pre-treatment of samples with propidium monoazide (PMA) is an effective approach to non-viable cell exclusion (NVCE) (Nocker and Camper, 2006) . In brief, PMA intercalates into double-stranded nucleic acids. On exposure to bright light, cross-linking occurs (Nocker and Camper, 2006) , preventing the DNA from acting as a PCR template (Nocker and Camper, 2006; Nocker et al., 2007a, b) . Importantly though, PMA is highly membrane impermeant (Nocker and Camper, 2006) . This means that although PMA is readily able to penetrate dead bacterial cells whose structural integrity has been lost, PMA is excluded from viable cells (Nocker and Camper, 2009) .
PMA treatment for this purpose has been shown to be effective in a range of contexts (Nocker et al., 2007a; Bae and Wuertz, 2009; Kralik et al., 2010; Nam et al., 2011; Taskin et al., 2011) , including the assessment of microbiota present in CF airway samples (Rogers et al., 2008 (Rogers et al., , 2010 . Further, this strategy has been used previously in conjunction with bacterial pyrosequencing in waste-water treatment systems . Although the benefits of NVCE are leading to its increasing deployment, its impact on microbial community data has not previously been determined.
In this study, the application of NVCE to profiling the bacterial communities present in spontaneously expectorated sputum samples collected from adult CF patients is detailed. The aim of this study was to determine the effects of PMA treatment on bacterial community characteristics (abundance, diversity, composition and structure), as analysed by 16S rRNA gene pyrosequencing, total bacterial Q-PCR enumeration and species-specific Q-PCR enumeration of Pseudomonas aeruginosa, a clinically important pathogen in CF airway disease (Ballmann et al., 1998; Kosorok et al., 2001) . Comparisons were made first between paired PMA-treated and non-PMA-treated samples (that is, the local community level), before focusing on core and satellite groups of bacterial taxa within the entire collection of PMA-and non-PMA-treated samples (that is, the metacommunity).
Materials and methods
Thirty spontaneously expectorated sputum samples were collected from adult CF patients attending the Adult CF Clinic at the Southampton General Hospital, with full ethical approval (Southampton and South West Hampshire Research Ethics Committee (06/Q1704/26)). All patients were judged to be clinically stable by treating physicians at the time of sampling. Sputum samples were collected in sterile containers, placed on ice and transported to the microbiology laboratory within 60 min. Samples were then frozen and stored at À 80 1C before analysis. Each sample was mixed by pipetting and divided into two equal portions, one of which was treated with PMA before DNA extraction.
PMA cross-linking PMA was dissolved in 20% dimethyl sulfoxide to create a stock concentration of 20 mmol l À 1 with this, added to samples to give a final concentration of 50 mmol l À 1 . Following an incubation period of 30 min in the dark with occasional mixing, samples were light exposed using LED Active Blue equipment (IB-Applied Science, Barcelona, Spain). After photo-induced cross-linking, cells were transferred to 1.5-ml microfuge tubes and pelleted at 5000 g for 5 min before DNA isolation.
DNA extraction
Nucleic acid extractions were performed on 100 ml portions of sputum. Guanidinium thiocyanate-EDTA-sarkosyl (500 ml) and phosphate-buffered saline (500 ml), pH 8.0, were added to samples. Cell disruption was achieved using a Fastprep-24 Instrument (MP Biomedicals Europe, Illkirch, France) 6.5 m s À 1 , 60 s, followed by incubation at 90 1C for 1 min and À 20 1C for 5 min. Cell debris was pelleted by centrifugation at 12 000 g for 2 min at 4 1C. Supernatant was transferred to a fresh microfuge tube. NaCl (to a final concentration of 0.5 mol l À 1 ) and polyethylene glycol (to a final concentration of 15%) were added, and DNA was precipitated at 4 1C for 30 min. DNA was pelleted by centrifugation at 12 000 g for 2 min at 4 1C and resuspended in 300 ml of sterile distilled water. Samples were heated at 90 1C for 30 s and vortexed. Phenol/chloroform (1:1) (300 ml) was added, and samples were vortexed for 20 s before centrifugation at 12 000 g at 4 1C for 3 min. The upper phase was then transferred to a fresh microfuge tube. Total DNA was then precipitated by the addition of an equal volume of isopropanol, a 0.1-volume of 10 mol l À 1 ammonium acetate and 1 ml of GenElute linear polyacrylamide (Sigma-Aldrich, Gillingham, UK) and incubated at À 20 1C for 25 min. DNA was pelleted by centrifugation at 12 000 g at 4 1C for 5 min. Pelleted DNA was then washed three times in 70% ethanol, dried and resuspended in 50 ml of sterile distilled water. DNA extracts were quantified using the Picodrop Microlitre Spectrophotometer (GRI, Braintree, UK).
Quantitative PCR All Q-PCR analyses were performed in triplicate. Total bacterial density was determined using a Taqman assay, in which a 466-bp fragment of the 16S ribosomal RNA gene was amplified, as described previously (Nadkarni et al., 2002) . P. aeruginosa density was determined using a Taqman assay, which amplified a 65-bp fragment of the regA gene, as described previously (Shannon et al., 2007; Rogers et al., 2010) . Details of the relevant primers and probes used are shown in Supplementary Table S1 .
Pyrosequencing
Bacterial tag-encoded FLX amplicon pyrosequencing was performed as described previously (using Gray28F 5 0 -TTTGATCNTGGCTCAG-3 0 and Gray519r 5 0 -GTNTTACNGCGGCKGCTG-3 0 ). Initial generation of the sequencing library involved a one-step PCR of 30 cycles, using a mixture of Hot Start and HotStar high-fidelity taq polymerase, as described previously (Dowd et al., 2008) . Tag-encoded FLX amplicon pyrosequencing analyses utilised Roche 454 FLX instrument (Roche, Branford, CT, USA) with Titanium reagents, titanium procedures performed at the Research and Testing Laboratory (Lubbock, TX, USA) using RTL protocols (www.researchand testing.com).
Sequence processing
Following sequencing, all failed sequence reads, low-quality sequence ends, and tags and primers were removed. Sequences with ambiguous base calls and sequences with homopolymers 46 bp were removed. Further, any non-bacterial ribosome sequences and chimeras were removed using Black Box Chimera Check software (B2C2) (Gontcharova et al., 2010) , as has been described previously (Dowd et al., 2008) . To determine the identity of bacteria in the remaining sequences, sequences were de-noised, assembled into OTU clusters at 97% identity and queried using a distributed NET algorithm that utilises Blastn þ (Kraken BLAST; www.krakenblast.com) against a database of high-quality 16S bacterial sequences. Using a NET and C# analysis pipeline, the resulting BLASTn þ outputs were compiled, and data reduction analysis was performed as described previously (Dowd et al., 2008) .
Bacterial identification
Based upon the above BLASTn þ -derived sequence identity (percent of total length query sequence that aligns with a given database sequence), the bacteria were classified at the appropriate taxonomic levels based upon the following criteria. Sequences with identity scores, to known or well-characterised 16S sequences, 497% identity (o3% divergence) were resolved at the species level, between 95% and 97% at the genus level, between 90% and 95% at the family and between 85% and 90% at the order level, 80% and 85% at the class and 77-80% at phyla. After resolution based upon these parameters, the percentage of each bacterial identity was individually analysed for each sample, providing relative abundance information within and among the individual samples based upon relative numbers of reads within each (Dowd et al., 2008) .
Statistical analyses
To determine whether sample sizes were large enough to effectively assess the diversity of bacteria in each of the sputum samples taken, a finite (without replacement) single-sample rarefaction was employed and calculated using the Species Diversity and Richness package (version 4.1.2; Pisces Conservation, Lymington, UK).
Meta-analyses were used to summarise the effect sizes of all 30 samples using Hedges' d effect size measure (Borenstein et al., 2009) , treating the different samples as independent of each other and the two treatments (PMA and non-PMA) as separate groups within samples. Per sample, the effect size (that is, standardized mean difference (d)) among treatments was expressed as:
In which X 1 and X 2 are the sample means in the two groups, n 1 and n 2 the sample sizes and S 1 and S 2 the s.d. within groups. The s.e. of mean per sample (s.e.m. d ) was expressed as:
Subsequently, the overall average effect size M was calculated, weighted by variance of sample i (V i ) and the s.e. of mean of M (s.e.m. M ) as:
Three complementary measurements of diversity were used to compare bacterial diversity between paired non-treated and PMA-treated samples, as previously described (Edwards et al., 2001) . The indices used were species richness (S*), ShannonWiener index (H 0 ), and Simpson's index (D). Differences in S*, H 0 and D (converted to the intuitive reciprocal form (1/D)) were computed using the re-sampling randomisation method of Solow (1993) . It is known that pairwise comparisons will be affected by large differences in sample size (N) (Gihring et al., 2012) . Therefore, an Excel macroprogram was written to apply Solow's method to the pairwise comparison of each of the three parameters (S*, H 0 and D) with a uniform sub-sample size (n ¼ 1637). The re-sampling was repeated 1000 times, and the mean similarity coefficients and s.d. were taken. The value of n ¼ 1637 was chosen to match to the smallest sample size. For metacommunity level analyses, the smallest sample size was chosen for each pairwise comparison.
The community compositions from paired samples were compared pairwise using the Sørensen similarity coefficient calculated from the numbers of shared species. To overcome differences in sample size (Gihring et al., 2012) , the similarity coefficients were calculated using an Excel macro-program written to re-sample each sample species list with a uniform sub-sample size (n ¼ 1637) and calculate the similarity coefficients (Solow, 1993) . The resampling was repeated 1000 times, and the mean similarity coefficients and s.d. were taken. For metacommunity level analyses, the smallest sample size was chosen for each pairwise comparison.
Poisson distribution tests were carried out according to the method described by Krebs (1999) and applied as previously described (van der Gast et al., 2011) . Regression analysis, coefficients of determination (r 2 ), residuals and significance (P) were calculated using Minitab software (version 14.2; Minitab, University Park, PA, USA).
Results and Discussion
The effect of PMA treatment on abundance Q-PCR-based enumeration using a conserved 16S rRNA gene primer pair and probe was performed on each of the 30 spontaneously expectorated sputum samples to determine the abundance of bacteria in paired PMA-treated and non-treated sputum samples (Figure 1a equivalents. Further, the abundance of only P. aeruginosa in paired samples was determined through Q-PCR using primers and a probe specific for P. aeruginosa Toxin A synthesis, regulating gene regA (Figure 1b) . The mean abundance of P. aeruginosa in non-PMA samples was 1.57 Â 10 8 ± 1.82 Â 10 8 CFU ml À 1 equivalents compared with 2.50 Â 10 7 ±1.82 Â 10 7 CFU ml À 1 equivalents in the PMA-treated samples, ranging from 4.47 Â 10 3 to 6.15 Â 10 8 and 1.64 Â 10 2 ± 1.49 Â 10 8 CFU ml À 1 equivalents for non-PMA and PMA-treated samples, respectively.
A growing number of studies have observed that bacterial communities are highly variable between CF patients (for example, Rogers et al., 2005 , Harris et al., 2007 , van der Gast et al., 2011 . To cover the large variation among samples, meta-analysis (Borenstein et al., 2009 ) was used to integrate effect sizes among sputum samples, that is, the difference between with and without prior PMA treatment. Meta-analysis is a statistical synthesis of different individual studies, used in medicine to test among different clinical trials (Borenstein et al., 2009) or in ecology among different experimental studies (Marvier et al., 2007) . Importantly, the number of replicates within individual studies and the variation among these replications are used as weighting of the means. Here, this was translated into using the replications within the same sample as a study, and so all paired samples as independent studies, hence, providing a powerful tool to study between sample effects rather than simply comparing means of individual samples by, for example, paired t-tests.
Using the meta-analysis approach to assess the effects of PMA treatment on total bacterial abundance and P. aeruginosa abundance demonstrated significant and strong negative effects on abundance for all paired samples (Figures 1c and d) .
The effects of PMA treatment on diversity and composition in local communities Targeted 454 high-throughput pyrosequencing was used to assess the diversity and composition of bacterial communities within each of the treated and non-treated paired samples. A total of 386 213 bacterial sequence reads (mean ¼ 6436.9±634.2 (n ¼ 60)), identifying 154 genera and 267 taxa, was generated from all of the sputum samples combined (Supplementary Tables S2 and S3 ). Rarefaction curves were used to test whether sample sizes per sample were sufficiently large to compare enough of the bacterial diversity (Supplementary Figure S1) ; this analysis indicated that richness values for the bacterial taxa sampled from all local communities became asymptotic or were approaching asymptotic status, providing stable estimates of diversity. In this way, confirmation that sufficiently large samples had been collected and bacterial diversity was not undersampled was obtained.
To avoid potential biases in comparisons of diversity between local communities due to varying number of sequences per sample (Gihring et al., 2012) , a randomised re-sampling method (with a uniform sub-sample size of n ¼ 1637) using three indices of diversity (taxa richness (S*), ShannonWiener index (H 0 ) and Simpson's reciprocal index (1/D)) was employed (Supplementary Table S2 ). For brevity, the effects of PMA treatment on taxa richness are presented in Figure 2a . Richness across individual samples, regardless of treatment, was highly variable, with mean values of 21.0±15.1 and 18.8±15.3, respectively. Meta-analysis of individual samples revealed both significant negative and positive effects on richness by PMA treatment (Figure 2b) .
Changes in community composition because of PMA treatment were also investigated. The Søren-sen index of similarity with a randomised resampling method (uniform sub-sample size of n ¼ 1637) revealed a mean change in similarity of 0.46±0.23 in PMA-treated samples when compared with paired non-PMA-treated samples (Figure 2c ). Meta-analysis showed significant negative effects (decreases in similarity) for all individual paired samples (Figure 2d ).
Overall effects of PMA treatment on abundance, diversity and composition When the overall effects of PMA treatment on different community characteristics were examined, a significant reduction was observed for both bacterial and P. aeruginosa abundance (Figure 3 ). This would indicate that only DNA from extant viable cells was included in the analyses, excluding extracelluar DNA and DNA from dead or damaged cells that would be otherwise incorporated into abundance measures using Q-PCR without prior PMA treatment. Although no overall significant effect on richness was observed, and hence diversity (confirmed using H 0 and 1/D measures of diversity (Figure 3) ), this indicated that diversity can be either under-or overestimated in local communities without prior PMA treatment (Figures 1 and 3 ). An overall significant negative effect on community composition was observed using the Sørensen index of similarity (Figure 3 ). This would indicate that skewed observations of local community composition are reached without prior PMA treatment. The effects of PMA treatment at the metacommunity level At the metacommunity level, it has been established that a dichotomy exists within metacommunity species abundance distributions (SADs), consisting of 'regionally' common and locally abundant core species and infrequent rare satellite species groups (for example, Magurran and Henderson, 2003; Ulrich and Zalewski, 2006; Dolan et al., 2009; Unterseher et al., 2011) . Recently, we established that the core-satellite group approach can be applied to CF bacterial communities and that partitioning the two groups from a metacommunity revealed important aspects of SADs, which would otherwise be neglected without such a distinction (van der Gast et al., 2011) . It is important to note that here we define 'core' and satellite species group set within a long established and defined ecological context (for example, Hanski, 1982; Magurran and Henderson, 2003) , which is specific to the particular metacommunity being studied (comprised of samples from distinct local communities). Therefore, it is possible that core and satellite groups can differ between defined metacommunities and studies.
In the current study, the same approach was employed to focus on PMA-treatment effects at the metacommunity level. To establish that the defined metacommunity, comprised of either the 30 PMAor non-treated local communities, was coherent, the relationship between mean abundance of taxa and local community occupancy/persistence was plotted (Figures 4a and b) . The expectation for a coherent metacommunity would be a 'regional' community comprised of trophically similar individuals and species, each of which is perceived to exist in a series of local communities from similar habitats linked by rationale dispersal of potentially interacting species between or into those local communities (that is, by dispersal from outside of the metacommunity) (Prosser et al., 2007) , resulting in a positive relationship between distribution among sites and abundance. Here significant distribution-abundance relationships were observed for both the PMA-and non-PMA-treated metacommunity (Figures 4a and b) . Therefore, as observed previously, the commonness and rarity of bacterial taxa in the treated or non-treated metacommunity was found to be related to their permanence (local communities occupied) (Hanski, 1982; Magurran and Henderson, 2003; van der Gast et al., 2011) .
Next, the treated and non-treated metacommunity SADs were objectively divided into core and satellite groups by decomposing the overall distribution using the ratio of variance to the mean abundance for each bacterial taxon (van der Gast et al., 2011). The variance to mean ratio, or index of dispersion, is an index used to model whether species follow a Poisson distribution, falling between 2.5% and 97.5% confidence limits of the w 2 distribution (Krebs, 1999) . Plotting the indices of dispersion against persistence throughout the 30 samples without prior PMA treatment, 32 bacterial taxa were randomly distributed through space (that is, those taxa that fall o2.5% confidence limit line in Figure 4c ). Bacterial taxa that occurred only in a single sputum sample were excluded from this analysis, as their dispersion in space would have no variance. However, those 49 taxa were classified into the satellite group (81 taxa in total), and the remaining 68 non-randomly distributed taxa were classified as core group taxa, in the non-PMAtreated metacommunity (see Supplementary Table  S3 for core and satellite identification). For the PMA-treated metacommunity, the satellite group was comprised of 163 taxa (with 112 taxa, each occurring in only one sample) and 70 core group taxa (Figure 4d) .
Following the categorisation of the CF bacterial taxa into the two groups, the metacommunity SADs with and without prior treatment were visualised as rank-abundance plots to examine differences in diversity and metacommunity structure ( Figure 5 ). The slope values for each plot were used as a descriptive statistic of evenness, where a value of zero represents perfect evenness (Ager et al., 2010) . A change in community structure was observed in the PMA-treated metacommunity (b ¼ À 0.0137) when compared with the non-treated metacommunity (b ¼ À 0.0244). Using the t-distribution test, Fowler et al. (1998) demonstrated that the slopes were significantly different (t ¼ 12.86; d.f. ¼ 1378; Po0.0001), indicating an increase in community structure evenness following PMA treatment. Furthermore, the changes in evenness were driven by changes in richness, where 149 taxa were observed in the non-PMA-treated metacommunity compared with 233 taxa in the PMA-treated metacommunity ( Figure 5 ). To address the issue of whether previously undetected extant taxa, without prior PMA treatment, were either core (regionally common and locally abundant) or satellite (infrequent and rare) members of the metacommunity. A total of 118 taxa were previously undetected, of which 106 were categorised as satellite group members and 12 taxa as core group members. Furthermore, a total of 34 taxa, comprised of 31 satellite group and only 3 core group members, was not detected after prior PMA treatment. Despite the inclusion of a small number of core taxa group members, it could be concluded that the majority of taxa, both newly detected and undetected after PMA treatment, were predominately infrequent rare members of the metacommunity.
Subsequently, to what extent this drove overall patterns of diversity and composition of the metacommunity was examined, by comparing mean richness and changes in composition for the whole metacommunity, and the core and satellite groups between treatments (Figure 6a ). Again to avoid potential biases in comparisons of diversity and composition between samples because of varying mean numbers of sequences, a randomised resampling method was used (with a uniform subsample size, using the lowest number of sequences in each pairwise comparison for the metacommunity (n ¼ 8172), core (n ¼ 6370) and satellite (n ¼ 214) taxa groups). Richness was significantly higher in the PMA-treated metacommunity when compared with the non-treated metacommunity, confirmed using meta-analysis (Figure 6c ). When partitioned into groups, PMA treatment did not lead to a significant change in core group richness, but a significant change in richness was observed in the satellite group, again demonstrating that the majority of previously undetected taxa belonged to the satellite group, which drove the changes in diversity of the overall metacommunity (Figures 6a and c) . Likewise, patterns similar to the observed changes in taxa richness were found for taxa composition, with overall significant changes in similarity in the PMA-treated metacommunity (change of 0.23 ± 0.01) and the satellite group (0.63 ± 0.03). Conversely, the composition of the core group was not significantly affected by PMA treatment (0.03±0.04) (Figures 6b  and d) .
Impact of PMA treatment on the detection of recognised and emergent CF pathogens Analysis of the detection of recognised and emergent CF pathogens in the metacommunity indicated that P. aeruginosa, Stenotrophomonas maltophilia and Streptococcus pneumoniae remained core group members, regardless of PMA treatment.
The most abundant taxon in the metacommunity, P. aeruginosa, was detected across the same 29 individual local communities, regardless of prior treatment; accounting for 76.1% (178952 of 235119) of total sequence reads without PMA and 77.1% (116444 of 151094) reads with PMA. However, the number of local communities in which S. maltophilia was detected increased from 10 (35 reads) to 16 (112 reads) with PMA. In contrast, the abundance and distribution of S. pneumoniae decreased from 14 (408 reads) to 7 (36 reads). Staphylococcus aureus (two samples) and the candidate pathogen Streptococcus intermedius (part of the Streptococcus milleri group (three samples)), both initially classified as satellite group members, were not detected with prior PMA treatment. Interestingly, four previously undetected taxa were detected in the metacommunity following PMA treatment. The recognised CF pathogens, Achromobacter xylosoxidans and Haemophilus influenzae were found to belong to the satellite group, being observed in three and one local communities, respectively. Members of the genus Mycobacterium, some of which are regarded as pathogens in CF, were also found to belong to the satellite group, being detected in one local community. Conversely, members of the Burkholderia genus that were found to belong to the core taxa group (seven samples and 83 reads), yet, were undetected without prior PMA treatment (Supplementary Table S3 ). The distribution of taxa in the metacommunity that are associated with the oral cavity according to the Human Oral Microbiome Database (Dewhirst et al., 2010) was also investigated. These taxa were found to be widely distributed across both the non-PMA-and PMA-treated metacommunity SADs (and therefore throughout both the core and satellite groups) (see Supplementary Table S3 ).
Conclusions
The lower respiratory system is a challenging environment for bacterial colonisation and persistence. Bacterial populations are subject to pressures from the host immune system and a wide variety of antimicrobial drugs. Antibiotic treatment is the mainstay of CF therapy, particularly in response to acute worsening of respiratory symptoms. To assess the effectiveness of such interventions, it is important that numbers of viable bacteria, and any reduction achieved as a result of therapy, can be accurately quantified. Our data indicate that DNA from non-viable bacteria and accumulated extracellular DNA make a significant contribution to estimations of bacterial abundance unless PMA treatment is employed. As such, this suggests that the inclusion of a PMA-treatment step is important for accurate Q-PCR-based enumeration.
As CF bacterial communities are known to contain a wide phylogenetic range of species, all of which can be expected to be affected to different degrees by antimicrobial therapy and immune response, the populations of those species are likely to be present in differing relative viable and non-viable proportions. Determining the impact of NVCE treatment on community characteristics was therefore of key importance in the present study. Our data indicate that contribution of DNA from non-viable sources prevents the accurate characterisation of CF bacterial communities by pyrosequencing.
We demonstrate that suppressing the contribution of DNA from non-viable sources is an important consideration for accurate characterisation of lower airway bacterial communities, in part, because this method further identifies bacterial taxa that would otherwise go undetected. Important from a clinical perspective is the detection of known CF pathogens (both core and satellite group members) only with NVCE, increasing the sensitivity of molecular analyses for these pathogens and providing vital information for prognosis and treatment. Here we have used CF bacterial communities as a paradigm for lower respiratory infections in general. Our findings suggest that a failure to implement a NVCE approach to analysing microbial communities may result in skewed results. As this effect is due to the contribution of DNA from non-viable sources, such approaches are appropriate where communities are under antimicrobial stress, and where a characterisation of the viable bacterial community is sought.
